PODOLSKI JOSEPH S
No ORCID on file
· 100 papers in corpus
· active 2008-2011
Frequent coauthors
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
The subject matter of the instant invention is pertinent to the field of treatment of hormone-dependent conditions. New compounds and methods for treating these conditions are disclosed. Embodiments of the instant invention disclose methods…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
Disclosed is use of a compound of formula (I): wherein the substituents are defined in the specification, or a pharmaceutically acceptable salt, hydrate or solvate thereof, for the manufacture of a medicament for treating endometriosis and/…
2011
2011
2011
2011
2011